Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Quarantelli

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2010
Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapyRoberta Lanzillo, Giuseppe Orefice, Mario Quarantelli, et al.
Journal of Neurology|June 28, 2011
A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal resultsFrancesco Saccà, Mario Quarantelli, Carlo Rinaldi, et al.
AJNR. American Journal of Neuroradiology|July 3, 2025
Predicting Ten-Year Clinical Outcomes in Multiple Sclerosis with Radiomics-Based Machine Learning ModelsMario Tranfa, Maria Petracca, Renato Cuocolo, et al.
European Radiology|March 14, 2022
Stratification of multiple sclerosis patients using unsupervised machine learning: a single-visit MRI-driven approachGiuseppe Pontillo, Simone Penna, Sirio Cocozza, et al.
Schizophrenia Bulletin|August 31, 2007
Patterns of structural MRI abnormalities in deficit and nondeficit schizophreniaSilvana Galderisi, Mario Quarantelli, Umberto Volpe, et al.
Clinical Immunology (Orlando, Fla.)|August 22, 2017
Immunometabolic profiling of patients with multiple sclerosis identifies new biomarkers to predict disease activity during treatment with interferon beta-1aRoberta Lanzillo, Fortunata Carbone, Mario Quarantelli, et al.
Nuclear Medicine and Biology|December 25, 2014
In vivo imaging and characterization of [(18)F]DPA-714, a potential new TSPO ligand, in mouse brain and peripheral tissues using small-animal PETCaterina Vicidomini, Mariarosaria Panico, Adelaide Greco, et al.
Journal of Neurology|April 14, 2009
Two novel CYP7B1 mutations in Italian families with SPG5: a clinical and genetic studyChiara Criscuolo, Alessandro Filla, Giovanni Coppola, et al.
Journal of Neurology|October 28, 2014
A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2Francesco Saccà, Giorgia Puorro, Arturo Brunetti, et al.
Insights Into Imaging|December 17, 2022
Clinical indications and acquisition protocol for the use of dynamic contrast-enhanced MRI in head and neck cancer squamous cell carcinoma: recommendations from an expert panelValeria Romeo, Arnaldo Stanzione, Lorenzo Ugga, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2010
Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapyRoberta Lanzillo, Giuseppe Orefice, Mario Quarantelli, et al.
Journal of Neurology|June 28, 2011
A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal resultsFrancesco Saccà, Mario Quarantelli, Carlo Rinaldi, et al.
AJNR. American Journal of Neuroradiology|July 3, 2025
Predicting Ten-Year Clinical Outcomes in Multiple Sclerosis with Radiomics-Based Machine Learning ModelsMario Tranfa, Maria Petracca, Renato Cuocolo, et al.
European Radiology|March 14, 2022
Stratification of multiple sclerosis patients using unsupervised machine learning: a single-visit MRI-driven approachGiuseppe Pontillo, Simone Penna, Sirio Cocozza, et al.
Schizophrenia Bulletin|August 31, 2007
Patterns of structural MRI abnormalities in deficit and nondeficit schizophreniaSilvana Galderisi, Mario Quarantelli, Umberto Volpe, et al.
Clinical Immunology (Orlando, Fla.)|August 22, 2017
Immunometabolic profiling of patients with multiple sclerosis identifies new biomarkers to predict disease activity during treatment with interferon beta-1aRoberta Lanzillo, Fortunata Carbone, Mario Quarantelli, et al.
Nuclear Medicine and Biology|December 25, 2014
In vivo imaging and characterization of [(18)F]DPA-714, a potential new TSPO ligand, in mouse brain and peripheral tissues using small-animal PETCaterina Vicidomini, Mariarosaria Panico, Adelaide Greco, et al.
Journal of Neurology|April 14, 2009
Two novel CYP7B1 mutations in Italian families with SPG5: a clinical and genetic studyChiara Criscuolo, Alessandro Filla, Giovanni Coppola, et al.
Journal of Neurology|October 28, 2014
A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2Francesco Saccà, Giorgia Puorro, Arturo Brunetti, et al.
Insights Into Imaging|December 17, 2022
Clinical indications and acquisition protocol for the use of dynamic contrast-enhanced MRI in head and neck cancer squamous cell carcinoma: recommendations from an expert panelValeria Romeo, Arnaldo Stanzione, Lorenzo Ugga, et al.
Pageof 10